A recent clinical study has shown that the CD14+ monocytes from multiple myeloma patients could be induced to differentiate into functional DCs by culturing them with the cytokine cocktail consisting of GM-CSF, IL-4, IL-6, TNF-α and IL-1β for use in cancer immunotherapy [36]. Here, IL6 is linked to plasma cell myeloma.